These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 14610192)
1. Quantitation of HLA class II protein incorporated into human immunodeficiency type 1 virions purified by anti-CD45 immunoaffinity depletion of microvesicles. Trubey CM; Chertova E; Coren LV; Hilburn JM; Hixson CV; Nagashima K; Lifson JD; Ott DE J Virol; 2003 Dec; 77(23):12699-709. PubMed ID: 14610192 [TBL] [Abstract][Full Text] [Related]
2. Differential incorporation of CD45, CD80 (B7-1), CD86 (B7-2), and major histocompatibility complex class I and II molecules into human immunodeficiency virus type 1 virions and microvesicles: implications for viral pathogenesis and immune regulation. Esser MT; Graham DR; Coren LV; Trubey CM; Bess JW; Arthur LO; Ott DE; Lifson JD J Virol; 2001 Jul; 75(13):6173-82. PubMed ID: 11390619 [TBL] [Abstract][Full Text] [Related]
3. Purification of HIV-1 virions by subtilisin digestion or CD45 immunoaffinity depletion for biochemical studies. Ott DE Methods Mol Biol; 2009; 485():15-25. PubMed ID: 19020815 [TBL] [Abstract][Full Text] [Related]
4. CD45 immunoaffinity depletion of vesicles from Jurkat T cells demonstrates that exosomes contain CD45: no evidence for a distinct exosome/HIV-1 budding pathway. Coren LV; Shatzer T; Ott DE Retrovirology; 2008 Jul; 5():64. PubMed ID: 18631400 [TBL] [Abstract][Full Text] [Related]
5. Efficient incorporation of HLA class II onto human immunodeficiency virus type 1 requires envelope glycoprotein packaging. Poon DT; Coren LV; Ott DE J Virol; 2000 Apr; 74(8):3918-23. PubMed ID: 10729169 [TBL] [Abstract][Full Text] [Related]
6. Microvesicles are a source of contaminating cellular proteins found in purified HIV-1 preparations. Bess JW; Gorelick RJ; Bosche WJ; Henderson LE; Arthur LO Virology; 1997 Mar; 230(1):134-44. PubMed ID: 9126269 [TBL] [Abstract][Full Text] [Related]
7. Highly purified human immunodeficiency virus type 1 reveals a virtual absence of Vif in virions. Dettenhofer M; Yu XF J Virol; 1999 Feb; 73(2):1460-7. PubMed ID: 9882352 [TBL] [Abstract][Full Text] [Related]
8. The conserved set of host proteins incorporated into HIV-1 virions suggests a common egress pathway in multiple cell types. Linde ME; Colquhoun DR; Ubaida Mohien C; Kole T; Aquino V; Cotter R; Edwards N; Hildreth JE; Graham DR J Proteome Res; 2013 May; 12(5):2045-54. PubMed ID: 23432411 [TBL] [Abstract][Full Text] [Related]
9. Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages. Chertova E; Chertov O; Coren LV; Roser JD; Trubey CM; Bess JW; Sowder RC; Barsov E; Hood BL; Fisher RJ; Nagashima K; Conrads TP; Veenstra TD; Lifson JD; Ott DE J Virol; 2006 Sep; 80(18):9039-52. PubMed ID: 16940516 [TBL] [Abstract][Full Text] [Related]
10. The presence of host-derived HLA-DR1 on human immunodeficiency virus type 1 increases viral infectivity. Cantin R; Fortin JF; Lamontagne G; Tremblay M J Virol; 1997 Mar; 71(3):1922-30. PubMed ID: 9032323 [TBL] [Abstract][Full Text] [Related]
11. Cytoskeletal proteins inside human immunodeficiency virus type 1 virions. Ott DE; Coren LV; Kane BP; Busch LK; Johnson DG; Sowder RC; Chertova EN; Arthur LO; Henderson LE J Virol; 1996 Nov; 70(11):7734-43. PubMed ID: 8892894 [TBL] [Abstract][Full Text] [Related]
12. Cholesterol depletion of human immunodeficiency virus type 1 and simian immunodeficiency virus with beta-cyclodextrin inactivates and permeabilizes the virions: evidence for virion-associated lipid rafts. Graham DR; Chertova E; Hilburn JM; Arthur LO; Hildreth JE J Virol; 2003 Aug; 77(15):8237-48. PubMed ID: 12857892 [TBL] [Abstract][Full Text] [Related]
13. Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), Is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus. Chertova E; Bess JW; Crise BJ; Sowder II RC; Schaden TM; Hilburn JM; Hoxie JA; Benveniste RE; Lifson JD; Henderson LE; Arthur LO J Virol; 2002 Jun; 76(11):5315-25. PubMed ID: 11991960 [TBL] [Abstract][Full Text] [Related]
14. Partial activation and induction of apoptosis in CD4(+) and CD8(+) T lymphocytes by conformationally authentic noninfectious human immunodeficiency virus type 1. Esser MT; Bess JW; Suryanarayana K; Chertova E; Marti D; Carrington M; Arthur LO; Lifson JD J Virol; 2001 Feb; 75(3):1152-64. PubMed ID: 11152488 [TBL] [Abstract][Full Text] [Related]
15. Major histocompatibility complex class II molecules promote human immunodeficiency virus type 1 assembly and budding to late endosomal/multivesicular body compartments. Finzi A; Brunet A; Xiao Y; Thibodeau J; Cohen EA J Virol; 2006 Oct; 80(19):9789-97. PubMed ID: 16973583 [TBL] [Abstract][Full Text] [Related]
16. Vif is largely absent from human immunodeficiency virus type 1 mature virions and associates mainly with viral particles containing unprocessed gag. Sova P; Volsky DJ; Wang L; Chao W J Virol; 2001 Jun; 75(12):5504-17. PubMed ID: 11356958 [TBL] [Abstract][Full Text] [Related]